Johann Matthias Graf von der Schulenburg : Citation Profile


Are you Johann Matthias Graf von der Schulenburg?

Leibniz Universität Hannover

6

H index

4

i10 index

141

Citations

RESEARCH PRODUCTION:

38

Articles

3

Papers

EDITOR:

1

Books edited

1

Series edited

RESEARCH ACTIVITY:

   32 years (1991 - 2023). See details.
   Cites by year: 4
   Journals where Johann Matthias Graf von der Schulenburg has often published
   Relations with other researchers
   Recent citing documents: 13.    Total self citations: 0 (0 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pgr520
   Updated: 2024-11-04    RAS profile: 2024-05-07    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Johann Matthias Graf von der Schulenburg.

Is cited by:

oliva, juan (6)

Baji, Petra (4)

TREICH, Nicolas (4)

Geyer, Johannes (4)

Korfhage, Thorben (4)

Brouwer, Werner (4)

Gollier, Christian (3)

Eling, Martin (3)

Péntek, Márta (3)

Hammitt, James (3)

Devlin, Nancy (3)

Cites to:

Eling, Martin (4)

Michel-Kerjan, Erwann (3)

Shah, Koonal (3)

Towse, Adrian (2)

Botzen, Wouter (2)

Brazier, John (2)

Claxton, Karl (2)

Sculpher, Mark (1)

Ortiz, Ramon (1)

Pohl, R. Vincent (1)

MARKANDYA, ANIL (1)

Main data


Where Johann Matthias Graf von der Schulenburg has published?


Journals with more than one article published# docs
The European Journal of Health Economics12
Health Economics Review10
The Geneva Papers on Risk and Insurance - Issues and Practice5
The Geneva Risk and Insurance Review3
Health Policy3

Recent works citing Johann Matthias Graf von der Schulenburg (2024 and 2023)


YearTitle of citing document
2023.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023Survival analysis of cancer patients in Portugal following the reference centre model implementation. (2023). Portugal, Rui ; Catalo-Lopes, Margarida ; Mateus, Manuel Melo. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01461-x.

Full description at Econpapers || Download paper

2023EQ-5D-5L: a value set for Romania. (2023). Vale, Luke ; Paveliu, Marian Sorin ; Niculescu-Aron, Ileana Gabriela ; Caplescu, Raluca ; Oluboyede, Yemi ; Mohammed, Wael ; Olariu, Elena. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:3:d:10.1007_s10198-022-01481-7.

Full description at Econpapers || Download paper

2023Does health technology assessment compromise access to pharmaceuticals?. (2023). Stargardt, Tom ; Bussgen, Melanie. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:3:d:10.1007_s10198-022-01484-4.

Full description at Econpapers || Download paper

2023Psychometric evaluation of the German version of the Recovering Quality of Life (ReQoL) measures in patients with affective disorders. (2023). Gallinat, Jurgen ; Keetharuth, Anju Devianee ; Konig, Hans-Helmut ; Grochtdreis, Thomas ; Dams, Judith ; Karow, Anne ; Lambert, Martin ; Schulz, Holger ; Konnopka, Alexander. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:4:d:10.1007_s10198-022-01489-z.

Full description at Econpapers || Download p

2023Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. (2023). Wang, Pei ; Luo, Nan ; Zhao, Chun-Hua ; Zhu, Yan-Bo ; He, Jun-Yi ; Pan, Chen-Wei. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01523-0.

Full description at Econpapers || Download paper

2023Willingness to pay for health gains from an international integrated early warning system for infectious disease outbreaks. (2023). Brouwer, Werner ; Exel, Job ; Himmler, Sebastian ; Perry-Duxbury, Meg. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01527-w.

Full description at Econpapers || Download paper

2023The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review. (2023). Drummond, Michael ; Nicod, Elena ; Meregaglia, Michela. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:7:d:10.1007_s10198-022-01541-y.

Full description at Econpapers || Download paper

2023Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D. (2023). Albus, Christian ; Weber, Cora ; Stolz, Maike ; Sollner, Wolfgang ; Schultz, Jobst-Hendrik ; Ronel, Joram ; Petrowski, Katja ; Michal, Matthias ; Herrmann-Lingen, Christoph ; Fritzsche, Kurt ; Deter, Hans-Christian ; Krauth, Christian ; Beutel, Manfred E ; Zwaan, Martina. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:8:d:10.1007_s10198-022-01543-w.

Full description at Econpapers || Download 2023

Diffusion of a new drug among ambulatory physicians—The impact of patient pathways. (2023). Sundmacher, Leonie ; Donnerbanzhoff, Norbert ; Frolich, Franziska ; Flemming, Ronja. In: Health Economics. RePEc:wly:hlthec:v:32:y:2023:i:4:p:970-982.

Full description at Econpapers || Download paper

Johann Matthias Graf von der Schulenburg is editor of


Journal
Health Economics Review

Johann Matthias Graf von der Schulenburg has edited the books:


YearTitleTypeCited

Works by Johann Matthias Graf von der Schulenburg:


YearTitleTypeCited
2014Entwicklung der Leistungsempfängerzahlen in der Gesetzlichen Pflegeversicherung - Zum Einfluss unterschiedlicher Morbiditätsannahmen auf die Entwicklung der sozialrechtlich anerkannten Pflegebedürftig In: Schmollers Jahrbuch : Journal of Applied Social Science Studies / Zeitschrift für Wirtschafts- und Sozialwissenschaften.
[Full Text][Citation analysis]
article0
2012Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study In: Health Policy.
[Full Text][Citation analysis]
article6
2022Amortization of gene replacement therapies: A health policy analysis exploring a mechanism for mitigating budget impact of high-cost treatments In: Health Policy.
[Full Text][Citation analysis]
article0
2002Diffusion of innovations: treatment of Alzheimers disease in Germany In: Health Policy.
[Full Text][Citation analysis]
article1
2015Cost of poor adherence to anti-hypertensive therapy in five European countries In: Post-Print.
[Citation analysis]
paper3
2014Grundlagen und Methoden von GKV-Routinedatenstudien In: Hannover Economic Papers (HEP).
[Full Text][Citation analysis]
paper3
2007Nach welchen ökonomischen Methoden sollten Gesundheitsleistungen in Deutschland evaluiert werden? / According to Which Economic Methods Should Health Care Services Become Evaluated in Germany? In: Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik).
[Full Text][Citation analysis]
article0
1991Reliability of Risk Management: Market Insurance, Self-Insurance and Self-Protection Reconsidered In: The Geneva Risk and Insurance Review.
[Full Text][Citation analysis]
article19
2009Reinsurance Brokers and Advice Quality: Is There a Need for Regulation? In: The Geneva Risk and Insurance Review.
[Full Text][Citation analysis]
article2
2012Corporate Management of Highly Dynamic Risks: Evidence from the Demand for Terrorism Insurance in Germany In: The Geneva Risk and Insurance Review.
[Full Text][Citation analysis]
article3
2010On the Impact of the Financial Crisis on the Dividend Policy of the European Insurance Industry In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
article3
2010Impact of the Introduction of the Social Long-Term Care Insurance in Germany on Financial Security Assessment in Case of Long-Term Care Need* In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
article8
2017An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
article0
2019Correction to: An Urban Crisis Management System for Critical Infrastructures: Participation Possibilities for Insurance Companies In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
article0
2020Affirmative and silent cyber coverage in traditional insurance policies: Qualitative content analysis of selected insurance products from the German insurance market In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]
article1
2013Cost of Poor Adherence to Anti-Hypertensive Therapy in Europe In: CEIS Research Paper.
[Full Text][Citation analysis]
paper0
2016Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2010Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2010EJHE has an official impact factor of 1.337 In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2011Letter from the editors In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2015Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article3
2016Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article15
2020HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article2
2021COVID-19: not the time for health economists? A plea for more proactive health economic involvement In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2002Commentary In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article3
2005Validating the EQ-5D with time trade off for the German population In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article20
2005German health care system in transition In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article4
2005Cost-effectiveness of outpatient treatment in depressive patients with escitalopram in Germany In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article1
2007Editor’s note In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2011Measuring economic consequences of preterm birth - Methodological recommendations for the evaluation of personal burden on children and their caregivers In: Health Economics Review.
[Full Text][Citation analysis]
article4
2011Greetings from the Editors In: Health Economics Review.
[Full Text][Citation analysis]
article0
2011Promoting vaccinations - an analysis of measures taken by German statutory health insurers In: Health Economics Review.
[Full Text][Citation analysis]
article0
2012Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany In: Health Economics Review.
[Full Text][Citation analysis]
article4
2013Impact of radiofrequency ablation for patients with varicose veins on the budget of the German statutory health insurance system In: Health Economics Review.
[Full Text][Citation analysis]
article0
2015Regional differences in health care of patients with inflammatory bowel disease in Germany In: Health Economics Review.
[Full Text][Citation analysis]
article0
2015Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosis - In: Health Economics Review.
[Full Text][Citation analysis]
article1
2016Benefit assessment in Germany: implications for price discounts In: Health Economics Review.
[Full Text][Citation analysis]
article3
2016Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks In: Health Economics Review.
[Full Text][Citation analysis]
article3
2018“Market withdrawals” of medicines in Germany after AMNOG: a comparison of HTA ratings and clinical guideline recommendations In: Health Economics Review.
[Full Text][Citation analysis]
article1
2018German Value Set for the EQ-5D-5L In: PharmacoEconomics.
[Full Text][Citation analysis]
article18
2023Digital Transformation in Back-Offices of German Insurance Companies In: International Journal of Innovation and Technology Management (IJITM).
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team